Business Context and Reporting Period
This Form 8-K reports on the results of Humana Inc.'s regular annual meeting of stockholders held on April 17, 2025. The filing discloses the voting outcomes for three proposals submitted to shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
A total of 105,203,172 shares were present by valid proxy, constituting a quorum. The results for the three proposals were as follows:
- Proposal #1 (Election of Directors): All 11 nominees were elected. While all directors received majority support, two nominees received significant "Against" votes:
- Karen W. Katz: 6,040,964 votes against (approx. 6.4% of votes cast).
- Frank A. D'Amelio: 6,022,785 votes against (approx. 6.4% of votes cast).
- Proposal #2 (Ratification of Auditors): The appointment of PricewaterhouseCoopers LLP for the year ending December 31, 2025, was approved with 98,877,049 votes "For" and 6,290,061 votes "Against".
- Proposal #3 (Executive Compensation): The non-binding advisory vote on executive compensation was approved with 89,310,631 votes "For" and 10,567,799 votes "Against" (approx. 10.6% against).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the specific reasons for the elevated "Against" votes (approx. 6.4%) for directors Karen W. Katz and Frank A. D'Amelio.
- Review the "Say on Pay" results, noting that over 10.5 million votes were cast against the executive compensation proposal.
- Confirm the term of office for the newly elected directors, which extends until the next annual meeting.